vancomycin has been researched along with carbonyl cyanide m-chlorophenyl hydrazone in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
| Aínsa, JA; Martín, C; Ramón-García, S; Thompson, CJ | 1 |
| Bremner, JB; Casadei, G; Chen, C; Doll, NK; Kelso, MJ; Lewis, K | 1 |
| Alam, MZ; Bruhn, DF; Feng, L; Hurdle, JG; Lee, RB; Lee, RE; Maddox, MM; Narula, G; Sandhaus, S; Simmons, CJ; Sun, D; Tse-Dinh, YC; Tsutsumi, LS; Wu, X | 1 |
| Chen, L; Cooper, B; Cushman, M; Mayhoub, A; Mohammad, H; Oldfield, E; Peters, CE; Pogliano, J; Pogliano, K; Seleem, MN; Younis, W; Zhang, J | 1 |
| Abouf, M; Abutaleb, NS; Chen, L; Elsebaei, MM; Ghiaty, A; Hegazy, YA; Malwal, SR; Mayhoub, AS; Mohammad, H; Oldfield, E; Seleem, MN; Zhang, J | 1 |
| Abouelhassan, Y; Garrison, AT; Huigens, RW; Jin, S; Kallifidas, D; Kim, YS; Luesch, H; Tan, H | 1 |
| Aldrich, CC; Cui, H; Ferguson, DM; Guo, K; Larson, P; Li, Y; Liu, X; Ma, C; Sheng, L; Wang, S; Wang, X; Zeng, Y; Zhang, G; Zhang, J; Zou, X | 1 |
| Bora, A; Deka, B; Devi, MV; Dihingia, A; Pahari, P; Sarma, S; Sen, T; Singh, AK; Suri, M | 1 |
| Andrés-Bilbao, M; Belmonte-Reche, E; Cebrián, R; de Paz, MV; Kuipers, OP; Li, Q; Lucas, R; Morales, JC; Peñalver, P | 1 |
| Grignon, C; Rossignol, M; Thomas, P | 1 |
| Bushrow, L; Calhoun, JH; Dusane, DH; Granger, JF; Kyrouac, D; Petersen, I; Phieffer, LS; Stoodley, P | 1 |
1 review(s) available for vancomycin and carbonyl cyanide m-chlorophenyl hydrazone
| Article | Year |
|---|---|
Chemically Tuning Resveratrol for the Effective Killing of Gram-Positive Pathogens.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Resveratrol | 2022 |
11 other study(ies) available for vancomycin and carbonyl cyanide m-chlorophenyl hydrazone
| Article | Year |
|---|---|
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
Topics: Antitubercular Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Clofazimine; Dithiothreitol; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Glutathione; Hydrogen Peroxide; Membrane Transport Proteins; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Rifampin; Valinomycin | 2009 |
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cell Cycle; Cell Line; Clostridioides difficile; Fidaxomicin; Humans; Hydrazones; Microbial Sensitivity Tests | 2014 |
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Topics: Animals; Anti-Bacterial Agents; Chalcones; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Chromones; DNA Gyrase; DNA Topoisomerase IV; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phloroglucinol; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2014 |
Phenylthiazole Antibacterial Agents Targeting Cell Wall Synthesis Exhibit Potent Activity in Vitro and in Vivo against Vancomycin-Resistant Enterococci.
Topics: Animals; Anti-Bacterial Agents; Caenorhabditis elegans; Cell Wall; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Models, Molecular; Thiazoles; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2017 |
Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Alkynes; Animals; Anti-Bacterial Agents; Half-Life; Methicillin-Resistant Staphylococcus aureus; Mice; Microsomes, Liver; Staphylococcal Infections; Thiazoles | 2018 |
An Efficient Buchwald-Hartwig/Reductive Cyclization for the Scaffold Diversification of Halogenated Phenazines: Potent Antibacterial Targeting, Biofilm Eradication, and Prodrug Exploration.
Topics: Anti-Bacterial Agents; Biofilms; Cyclization; Halogenation; HeLa Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phenazines | 2018 |
A Cinchona Alkaloid Antibiotic That Appears To Target ATP Synthase in Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Binding Sites; Cinchona Alkaloids; Drug Resistance, Microbial; Microbial Sensitivity Tests; Mitochondrial Proton-Translocating ATPases; Streptococcus pneumoniae; Structure-Activity Relationship | 2019 |
Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship; THP-1 Cells | 2022 |
Proton permeability of liposomes from natural phospholipid mixtures.
Topics: Carbonyl Cyanide m-Chlorophenyl Hydrazone; Hydrogen-Ion Concentration; Kinetics; Lipid Bilayers; Membrane Fluidity; Permeability; Thermodynamics; Vancomycin | 1982 |
Targeting intracellular Staphylococcus aureus to lower recurrence of orthopaedic infection.
Topics: Alkaloids; Anti-Bacterial Agents; Benzodioxoles; Bone Morphogenetic Protein 2; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Line, Tumor; Dicloxacillin; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Host-Pathogen Interactions; Humans; Microbial Sensitivity Tests; Osteoblasts; Osteomyelitis; Piperidines; Polyunsaturated Alkamides; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2018 |